Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

"Exact Sciences团队很自豪能够通过与Humana的合作扩大Cologuard Plus的使用范围，使更多人能够在家中舒适地使用这种革命性的非侵入性结直肠癌筛查测试，"Exact Sciences筛查部门执行副总裁兼总经理Jake Orville表示。

CMS denied an appeal from Humana over its star ratings scores, with the lawsuit's outcome yet to be determined.

Seen and head at the Cologuard Classic: Cologuard ambassador Jerry Kelly (shoulder) forced to withdraw; improving weather; "Chloe the Giant Colon"; and more.

Humana refiles Medicare Advantage star ratings suit Humana is taking a second bite at the apple to improve its sunken MA stars, filing an edited complaint with a Texas court on Monday. The insurer ...

Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments.

Humana Inc. shares fell after it lost a lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped the court would restore billions in revenue.

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the health insurer's star ratings for government-backed Medicare plans.

Humana Inc. shares fell after it lost a lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped the court would restore billions in revenue.

Humana Inc (NYSE: HUM) has hit a 52-week low, with its stock price falling to 212.33 USD. This marks a significant downturn for the company, as it reflects a 42.31% decline over the past year.

By Nicholas G. Miller Humana lost its legal challenge to restore the quality ratings of its Medicare plans in a significant blow to future earnings potential.